GVHD
GVHD
Advertisement
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | October 1, 2024
It's critical for oncology nurses to encourage these patients to monitor their blood pressure at home.
Read More
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | October 1, 2024
Renal toxicity occurs in approximately 75% of all patients who receive allogeneic stem cell transplants.
Cancer Nursing Today EditorsGVHD | September 12, 2024
A new study highlights the importance of effective management and close monitoring of GVHD.
Katie KoskoGVHD | August 30, 2024
Learn how an early intervention with oral mucosal barrier protective agents can help patients with chronic oral GVHD.
Katie KoskoGVHD | August 29, 2024
Learn what a team in Sweden found when they began offering home care after allogeneic HSCT for patients who lived nearby.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | August 23, 2024
Learn how oncology nurses can address the challenges associated with early detection, diagnosis, and management.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | August 22, 2024
It's critical for oncology nurses understand and recognize the 3 atypical lung cGVHD conditions.
Katie KoskoGVHD | August 20, 2024
A small study evaluated the ROCK2 inhibitor for treatment of ocular GVHD because corneal epithelial cells express ROCK2.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | August 6, 2024
Oncology nurses must familiarize themselves with CNS and PNS cGVHD to improve patient outcomes.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | August 5, 2024
With better understanding of CNS cGVHD, oncology nurses can help ensure early recognition and reporting.
Katie KoskoGVHD | July 26, 2024
In the United States, 33%-50% of patients receiving an allogeneic transplant develop acute GVHD.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | July 9, 2024
There are 5 types of immune-mediated cytopenias, each with provisional diagnostic criteria.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | July 9, 2024
Nurses have a critical role in managing cGVHD-related serositis, including patient assessment, direct care, and education.
Katie KoskoConferences | July 5, 2024
Researchers presented real-world data on the cGVHD treatment during the EHA 2024 Congress.
Katie KoskoGVHD | July 4, 2024
Certain predictive markers may help identify patients who "experience significant benefits" from upfront use of this therapy.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | June 27, 2024
Since TAC levels must remain in a therapeutic range, oncology nurses often draw blood levels before the morning dose.
Mairéad Ní Chonghaile, RGN, BNS, MScConferences | June 27, 2024
Mairéad Ní Chonghaile, RGN, BNS, MSc, speaks about the importance of staying current on the latest updates in the field.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | June 26, 2024
Although the term “atypical cGVHD” is imperfect, it describes a form of cGVHD that doesn’t fit neatly into classic ...
Katie KoskoGVHD | August 8, 2024
Nearly all patients in the study had steroid-dependent chronic GVHD, and nearly half had severe chronic GHVD.
Cecilia BrownGVHD | June 6, 2024
A new study shows why it's important for nurses to help optimize health care resource availability for certain patients.
Advertisement
Advertisement
Advertisement